Gilead Sciences, Inc. (GILD) will begin trading ex-dividend on September 12, 2019. A cash dividend payment of $0.63 per share is scheduled to be paid on September 27, 2019. Shareholders who purchased GILD prior to the ex-dividend date are eligible for the cash dividend payment. This marks the 3rd quarter that GILD has paid the same dividend. At the current stock price of $67.08, the dividend yield is 3.76%.
The previous trading day's last sale of GILD was $67.08, representing a -15.74% decrease from the 52 week high of $79.61 and a 11.21% increase over the 52 week low of $60.32.
GILD is a part of the Health Care sector, which includes companies such as Amgen Inc. (AMGN) and Biogen Inc. (BIIB). GILD's current earnings per share, an indicator of a company's profitability, is $4.61. Zacks Investment Research reports GILD's forecasted earnings growth in 2019 as 8.23%, compared to an industry average of %.
Interested in gaining exposure to GILD through an Exchange Traded Fund [ETF]?
The following ETF(s) have GILD as a top-10 holding:
- iShares Nasdaq Biotechnology Index Fund (IBB)
- VanEck Vectors Biotech ETF (BBH)
- Invesco Dynamic Biotech & Genome ETF (PBE)
- Invesco Dynamic Pharmaceuticals ETF (PJP)
- iShares U.S. ETF Trust (IEIH).
The top-performing ETF of this group is IEIH with an increase of 0.35% over the last 100 days. IBB has the highest percent weighting of GILD at 8.44%.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.